Dag Hjelle • 1959 • Oslo • 14 roles • 7 shareholdings

This website uses cookies to enhance the user experience.

||

Roles

Management

Name	Role	Total operating income	Total equity	Shares
M MEDCIS AS	Managing Director/CEO	481,172	215,685	100 % directly
F FJORD MEDICAL AS	Managing Director/CEO	-	138,293	100 % indirectly
F FOLVENGAARD AQUA AS	Managing Director/CEO	-	534,500	48 % indirectly
P PURECUT TECHNOLOGIES AS	Managing Director/CEO	-	1,019,503	33.33 % indirectly

Boards

Name	Role	Total operating income	Total equity	Shares
M MEDCIS AS	Chairman	481,172	215,685	100 % directly
F FJORD MEDICAL AS	Chairman	-	138,293	100 % indirectly
F FOLVENGAARD AS	Chairman	5,628,191	45,463	60 % directly
F FOLVENGAARD AQUA AS	Chairman	-	534,500	48 % indirectly
P PURECUT TECHNOLOGIES AS	Chairman	-	1,019,503	33.33 % indirectly
B BIOSYNTECH AS	Board Member	452,270	228,316	20 % indirectly
H HJELLEDALEN KRAFTLAG AS	Board Member	1,563,559	2,545,246	9.52 % directly
F FOLVENGAARD BIOGAS AS	Chairman	-	-	-
D DAG HJELLE	Holder	-	-	-
B BÆREKRAFTIG LAKS AS	Board Member	-	399,614	-

Last update: Feb 21, 2026

Related industries3

Direct relationships5

Shares owned by Dag Hjelle

Name	Share class	Total operating income	Total equity	Share
M MEDCIS AS	Ordinære aksjer	481,172	215,685	100 % directly
F FJORD MEDICAL AS		0	138,293	100 % indirectly
F FOLVENGAARD AS	Ordinære aksjer	5,628,191	45,463	60 % directly
F FOLVENGAARD AQUA AS		0	534,500	48 % indirectly
P PURECUT TECHNOLOGIES AS		0	1,019,503	33.33 % indirectly
B BIOSYNTECH AS		452,270	228,316	20 % indirectly
H HJELLEDALEN KRAFTLAG AS	Ordinære aksjer	1,563,559	2,545,246	9.52 % directly

Limited to direct ownership positions of 0.5% or more.

Last update: Jun 2, 2025